Free webinars on the advantages, applications, and availability of animal-free antibodies

Home / Community Blog / Free webinars on the advantages, applications, and availability of animal-free antibodies

Community Blog

Free webinars on the advantages, applications, and availability of animal-free antibodies

Join us for these free upcoming webinars on the scientific and economic advantages of animal-free antibodies, their recent novel applications, and services to produce recombinant antibodies.

Date: September 16, 2020
Time: 10:00–11:00 am EDT (4:00–5:00 pm CEST)
More information and registration link here: https://www.piscltd.org.uk/antibody-webinars/

  • Dr. Alison Gray (Afability) will discuss how animal-free antibodies are developed, how they mimic the mechanistic principles evolved by nature, and the challenges that have slowed their replacement.
  • Dr João Barroso (EURL ECVAM) will share a summary of the findings from a 2018 EURL ECVAM Scientific Advisory Committee (ESAC) meeting that reviewed the validity and benefits of using animal-free technology to produce affinity reagents and the subsequent EURL ECVAM recommendation.

Date: October 15, 2020
Time: 10:00–11:00 am EDT (4:00–5:00 pm CEST)
More information and registration link here: https://www.piscltd.org.uk/antibody-webinars/

  • Dr Giulio Russo (Abcalis) will speak on the replacement of animal serum-derived secondary antibodies with animal-free multiclonal antibodies.
  • Dr Charu Chandrasekera (Canadian Centre for Alternatives to Animal Methods) will provide an in-depth look at her experience replacing animal-derived affinity reagents in the laboratory.

Date: November 12, 2020
Time: 10:00–11:00 am EDT (4:00–5:00 pm CEST)
More information and registration link here: https://www.piscltd.org.uk/antibody-webinars/

  • Dr. Pierre Cosson (University of Geneva) will describe the work of the Geneva Antibody Facility and the antibody discovery and production services that they offer to the scientific community.
  • Dr. Michael Fiebig (Absolute Antibody) will provide insight on Absolute Antibody’s services sequencing existing hybridoma and ascites-derived antibodies to make them recombinantly.

* Webinars are co-organized by the US National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM), the PETA International Science Consortium Ltd., and the European Union Reference Laboratory for alternatives to animal testing (EURL ECVAM).